Beban M, Miller P S
Department of Biochemistry and Molecular Biology, School of Public Health, The Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.
Biochim Biophys Acta. 2000 Jun 21;1492(1):155-62. doi: 10.1016/s0167-4781(00)00107-x.
Triplex forming oligonucleotides (TFOs) are potentially useful in targeting RNA for antisense therapeutic applications. To determine the feasibility of targeting polypurine RNA with nuclease-resistant oligonucleotides, TFOs containing 2'-deoxy or 2'-O-methyl (2'-OMe) backbones, designed to form pyrimidine motif triplexes with RNA, were synthesized. TFOs were made which can form trimolecular triplexes, or bimolecular, 'clamp' triplexes with polypurine RNA and DNA. It was found that the relative stabilities of the triplexes formed followed the order: M.DM(clamp)>>>D.DD approximately M.DD>M. RM>D.DM>M.RD approximately M.DM, where M is a 2'-OMe, D is a DNA and R is an RNA backbone. The third strand is listed first, separated by a dot from the purine strand of the Watson-Crick duplex, followed by the pyrimidine strand of the duplex. The results described here provide insight into the feasibility of using TFOs containing a 2'-OMe backbone as antisense agents.
三链形成寡核苷酸(TFOs)在针对RNA进行反义治疗应用方面具有潜在的用途。为了确定用核酸酶抗性寡核苷酸靶向多嘌呤RNA的可行性,合成了含有2'-脱氧或2'-O-甲基(2'-OMe)骨架的TFOs,其设计用于与RNA形成嘧啶基序三链体。制备了能够与多嘌呤RNA和DNA形成三分子三链体或双分子“钳形”三链体的TFOs。发现形成的三链体的相对稳定性遵循以下顺序:M.DM(钳形)>>>D.DD≈M.DD>M.RM>D.DM>M.RD≈M.DM,其中M是2'-OMe,D是DNA,R是RNA骨架。第三条链首先列出,与沃森-克里克双链体的嘌呤链用点隔开,接着是双链体的嘧啶链。此处描述的结果为使用含有2'-OMe骨架的TFOs作为反义剂的可行性提供了见解。